Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical Applications of Chromosomal Microarray Testing in Myeloid Malignancies.

Current hematologic malignancy reports - 1 Jun 2020

Ronaghy Arash, Yang Richard K, Khoury Joseph D, Kanagal-Shamanna Rashmi

Abstract excerpt

PURPOSE OF REVIEW: Knowledge of both somatic mutations and copy number aberrations are important for the understanding of cancer pathogenesis and management of myeloid neoplasms. The currently available standard of care technologies for copy number assessment such as conventional karyotype and FISH are either limited by low resolution or restriction to targeted assessment. RECENT FINDINGS: Chromosomal microarray...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromosome Aberrations
Share to Chromosomes, Human

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Comparative Genomic Hybridization

Share to Leukemia, Myeloid, Acute

Share to Leukemia, Myelomonocytic, Chronic

Share to Loss of Heterozygosity

Share to Microarray Analysis

Share to Myelodysplastic Syndromes

Source

Identifiers

PMID: 32382988
DOI: 10.1007/s11899-020-00578-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical Applications of Chromosomal Microarray Testing in Myeloid Malignancies.PMID 32382988Read ↗

Detection of copy number alterations in acute myeloid leukemia and myelodysplastic syndromes.Semantic proximity Read ↗

Addition of chromosomal microarray and next generation sequencing to FISH and classical cytogenetics enhances genomic profiling of myeloid malignancies.Semantic proximity Read ↗

Assessing copy number abnormalities and copy-neutral loss-of-heterozygosity across the genome as best practice in diagnostic evaluation of acute myeloid leukemia: An evidence-based review from the cancer genomics consortium (CGC) myeloid neoplasms working groupSemantic proximity Read ↗

The Utilization of Chromosomal Microarray Technologies for Hematologic Neoplasms: An ACLPS Critical Review.Semantic proximity Read ↗

The use of cytogenetic microarrays in myelodysplastic syndrome characterization.Semantic proximity Read ↗

Genomic analysis of acute myeloid leukemia: potential for new prognostic indicators.Semantic proximity Read ↗

Assessing copy number aberrations and copy neutral loss of heterozygosity across the genome as best practice: An evidence based review of clinical utility from the cancer genomics consortium (CGC) working group for myelodysplastic syndrome, myelodysplastic/myeloproliferative and myeloproliferative neoplasmsSemantic proximity Read ↗

Genome-wide arrays in routine diagnostics of hematological malignancies.Semantic proximity Read ↗

Molecular findings in myeloid neoplasms.Semantic proximity Read ↗

Integration of microarray analysis into the clinical diagnosis of hematological malignancies: How much can we improve cytogenetic testing?Semantic proximity Read ↗

Development and validation of a comprehensive genomic diagnostic tool for myeloid malignancies.Semantic proximity Read ↗

Frequent genomic abnormalities in acute myeloid leukemia/myelodysplastic syndrome with normal karyotype.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.